Increased identification of novel variants in type 2 diabetes, birth weight and their pleiotropic loci

Journal of Diabetes

Volumn 9, Issue 10, 2017, Pages 898-907

  Zeng, Chun Ping ^a,b   Chen, Yuan Cheng ^a   Lin, Xu ^a   Greenbaum, Jonathan ^d   Chen, You Ping ^b   Peng, Cheng ^a   Wang, Xia Fang ^a   Zhou, Rou ^a   Deng, Wei Min ^c   Shen, Jie ^a   Deng, Hong Wen ^a,d  

^a THE THIRD AFFILIATED HOSPITAL OF SOUTHERN MEDICAL UNIVERSITY   (China)

^b The Second People s Hospital of Nanhai District   (China)

^c GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

^d TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

birth weight; genome wide association study; pleiotropy; type 2 diabetes

Indexed keywords

ADENYLATE CYCLASE; ADENYLATE CYCLASE 5; CYCLIN DEPENDENT KINASE 5; RNA POLYMERASE II; UNCLASSIFIED DRUG;

ADRB1 GENE; ARTICLE; BIRTH WEIGHT; CHROMOSOME; CPEB3 GENE; DISEASE PREDISPOSITION; FIBROBLAST; GENE; GENE TARGETING; GENETIC VARIABILITY; GENOME-WIDE ASSOCIATION STUDY; HUMAN; KCBQ1 GENE; LIVER CELL; MTNR1B GENE; NON INSULIN DEPENDENT DIABETES MELLITUS; OSTEOBLAST; PBX GENE; PBX4 GENE; PLEIOTROPY; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; FALSE POSITIVE RESULT; GENE LOCUS; GENE REGULATORY NETWORK; GENETIC PREDISPOSITION; GENETICS; INFORMATION PROCESSING; META ANALYSIS (TOPIC); STANDARDS; STATISTICS AND NUMERICAL DATA; TRENDS;

BIRTH WEIGHT; DATASETS AS TOPIC; DIABETES MELLITUS, TYPE 2; FALSE POSITIVE REACTIONS; GENE REGULATORY NETWORKS; GENETIC LOCI; GENETIC PLEIOTROPY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; META-ANALYSIS AS TOPIC; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 85010908941     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/1753-0407.12510     Document Type: Article

References (35)

1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2009; 32 (Suppl. 1): S62–S67.
2. Ozcan U, Cao Q, Yilmaz E et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science. 2004; 306: 457–461.
3. NCD Risk Factor Collaboration. Worldwide trends in diabetes since 1980: A pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016; 387: 1513–1530.
4. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27: 1047–1053.
5. Saddik B, Al-Dulaijan N. Diabetic patients’ willingness to use tele-technology to manage their disease: A descriptive study. Online J Public Health Inform. 2015; 7: e214.
6. Gluckman PD, Hanson MA, Bateson P et al. Towards a new developmental synthesis: Adaptive developmental plasticity and human disease. Lancet. 2009; 373: 1654–1657.
7. Zimmermann E, Gamborg M, Sorensen TI, Baker JL. Sex differences in the association between birth weight and adult type 2 diabetes. Diabetes. 2015; 64: 4220–4225.
8. Wang T, Huang T, Li Y et al. Low birthweight and risk of type 2 diabetes: A Mendelian randomisation study. Diabetologia. 2016; 59: 1920–1927.
9. Andersson EA, Pilgaard K, Pisinger C et al. Type 2 diabetes risk alleles near ADCY5, CDKAL1 and HHEX-IDE are associated with reduced birthweight. Diabetologia. 2010; 53: 1908–1916.
10. Ali O. Genetics of type 2 diabetes. World J Diabetes. 2013; 4: 114–123.
11. Magnus P, Gjessing HK, Skrondal A, Skjaerven R. Paternal contribution to birth weight. J Epidemiol Community Health. 2001; 55: 873–877.
12. Andreassen OA, Thompson WK, Schork AJ et al. Improved detection of common variants associated with schizophrenia and bipolar disorder using pleiotropy-informed conditional false discovery rate. PLoS Genet. 2013; 9: e1003455.
13. Morris AP, Voight BF, Teslovich TM et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet. 2012; 44: 981–990.
14. Horikoshi M, Yaghootkar H, Mook-Kanamori DO et al. New loci associated with birth weight identify genetic links between intrauterine growth and adult height and metabolism. Nat Genet. 2013; 45: 76–82.
15. Liley J, Wallace C. A pleiotropy-informed Bayesian false discovery rate adapted to a shared control design finds new disease associations from GWAS summary statistics. PLoS Genet. 2015; 11: e1004926.
16. Yekutieli D, Benjamini Y. Resampling-based false discovery rate controlling multiple test procedures for correlated test statistics. J Stat Plann Inference. 1999; 82: 171–196.
17. Elbein SC, Gamazon ER, Das SK, Rasouli N, Kern PA, Cox NJ. Genetic risk factors for type 2 diabetes: A trans-regulatory genetic architecture? Am J Hum Genet. 2012; 91: 466–477.
18. Unoki H, Takahashi A, Kawaguchi T et al. SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations. Nat Genet. 2008; 40: 1098–1102.
19. Hanson RL, Guo T, Muller YL et al. Strong parent-of-origin effects in the association of KCNQ1 variants with type 2 diabetes in American Indians. Diabetes. 2013; 62: 2984–2991.
20. Zhao J, Li M, Bradfield JP et al. Examination of type 2 diabetes loci implicates CDKAL1 as a birth weight gene. Diabetes. 2009; 58: 2414–2418.
21. Travers ME, Mackay DJ, Dekker Nitert M et al. Insights into the molecular mechanism for type 2 diabetes susceptibility at the KCNQ1 locus from temporal changes in imprinting status in human islets. Diabetes. 2013; 62: 987–992.
22. Saxena R, Elbers CC, Guo Y et al. Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci. Am J Hum Genet. 2012; 90: 410–425.
23. Sanguinetti MC, Curran ME, Zou A et al. Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel. Nature. 1996; 384: 80–83.
24. Ashcroft FM. ATP-sensitive potassium channelopathies: Focus on insulin secretion. J Clin Invest. 2005; 115: 2047–2058.
25. Torekov SS, Iepsen E, Christiansen M et al. KCNQ1 long QT syndrome patients have hyperinsulinemia and symptomatic hypoglycemia. Diabetes. 2014; 63: 1315–1325.
26. Adamska M, MacDonald BT, Sarmast ZH, Oliver ER, Meisler MH. En1 and Wnt7a interact with Dkk1 during limb development in the mouse. Dev Biol. 2004; 272: 134–144.
27. Li X, Shan J, Chang W et al. Chemical and genetic evidence for the involvement of Wnt antagonist Dickkopf2 in regulation of glucose metabolism. Proc Natl Acad Sci U S A. 2012; 109: 11402–11407.
28. Rulifson IC, Karnik SK, Heiser PW et al. Wnt signaling regulates pancreatic beta cell proliferation. Proc Natl Acad Sci U S A. 2007; 104: 6247–6252.
29. Jin T. The Wnt signalling pathway and diabetes mellitus. Diabetologia. 2008; 51: 1771–1780.
30. Yi F, Sun J, Lim GE, Fantus IG, Brubaker PL, Jin T. Cross talk between the insulin and Wnt signaling pathways: Evidence from intestinal endocrine l cells. Endocrinology. 2008; 149: 2341–2351.
31. Steinthorsdottir V, Thorleifsson G, Reynisdottir I et al. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet. 2007; 39: 770–775.
32. Buysse K, Reardon W, Mehta L et al. The 12q14 microdeletion syndrome: Additional patients and further evidence that HMGA2 is an important genetic determinant for human height. Eur J Med Genet. 2009; 52: 101–107.
33. Markowski DN, Thies HW, Gottlieb A et al. HMGA2 expression in white adipose tissue linking cellular senescence with diabetes. Genes Nutr. 2013; 8: 449–456.
34. 2B adenosine receptor modulates glucose homeostasis and obesity. PLoS One. 2012; 7: e40584.
35. Wang KC, Lim CH, McMillen IC, Duffield JA, Brooks DA, Morrison JL. Alteration of cardiac glucose metabolism in association to low birth weight: Experimental evidence in lambs with left ventricular hypertrophy. Metabolism. 2013; 62: 1662–1672.